
AVITA Medical RCEL
$ 3.99
3.91%
Annual report 2025
added 02-12-2026
AVITA Medical Total Assets 2011-2026 | RCEL
Total Assets — these are all the resources owned by the business that have economic value. They are used to operate the business, generate profit, and ensure the company’s stability.Main categories of assets
Current assets (used within one year):
- Cash and cash equivalents
- Accounts receivable (amounts owed by customers)
- Inventory of goods, raw materials, and supplies
- Short-term investments
- Fixed assets (buildings, machinery, equipment)
- Intangible assets (brands, patents, software)
- Long-term investments
- Goodwill (reputational value from mergers)
Assets represent an objective measure of a business's value, reflecting everything behind it: physical infrastructure, technology, customer base, and financial resources. A high share of liquid assets such as cash indicates a company’s financial flexibility and its ability to maintain stability in changing market conditions.
Asset analysis helps assess how effectively a company utilizes its resources to generate revenue and profit, reflecting its operational efficiency and ability to convert invested capital into financial results.
Annual Total Assets AVITA Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56.4 M | 79.7 M | 112 M | 98.3 M | 116 M | 82.5 M | 25.7 M | 16.9 M | 5.89 M | 6.42 M | 4.17 M | 6.89 M | 11.8 M | 11 M | 18.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 116 M | 4.17 M | 43.5 M |
Quarterly Total Assets AVITA Medical
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 63.7 M | 69.6 M | 79.7 M | 81.1 M | 87.8 M | 97.4 M | 112 M | 81 M | 86.3 M | 92.6 M | 98.3 M | 99.9 M | 103 M | 106 M | 116 M | 121 M | 126 M | 126 M | 69.3 M | 75.4 M | 82.5 M | 82.5 M | - | - | 25.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 126 M | 25.8 M | 90.5 M |
Total Assets of other stocks in the Medical devices industry
| Issuer | Total Assets | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
842 K | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
224 M | - | - | $ 1.77 B | ||
|
Insulet Corporation
PODD
|
3.19 B | $ 216.0 | -4.21 % | $ 15.2 B | ||
|
Axonics Modulation Technologies
AXNX
|
659 M | - | - | $ 3.31 B | ||
|
Aziyo Biologics
AZYO
|
62.4 M | - | 1.37 % | $ 20.5 M | ||
|
Profound Medical Corp.
PROF
|
43.9 M | $ 5.82 | 13.01 % | $ 180 M | ||
|
Acutus Medical
AFIB
|
54 M | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
19.7 M | - | 3.58 % | $ 2.21 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
10.6 M | - | -5.86 % | $ 30.6 M | ||
|
Second Sight Medical Products
EYES
|
41.6 M | - | -0.97 % | $ 54.4 M | ||
|
Quanterix Corporation
QTRX
|
419 M | $ 3.96 | 3.66 % | $ 169 M | ||
|
Conformis
CFMS
|
94 M | - | - | $ 16.4 M | ||
|
Cardiovascular Systems
CSII
|
323 M | - | 0.15 % | $ 844 M | ||
|
IRIDEX Corporation
IRIX
|
34.4 M | $ 1.33 | -1.85 % | $ 21.5 M | ||
|
Apollo Endosurgery
APEN
|
110 M | - | - | $ 475 M | ||
|
IRadimed Corporation
IRMD
|
109 M | $ 101.78 | 0.8 % | $ 1.29 B | ||
|
Avinger
AVGR
|
13.8 M | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
789 M | - | -4.14 % | $ 702 M | ||
|
Sintx Technologies
SINT
|
9.51 M | $ 2.56 | -0.39 % | $ 7.1 M | ||
|
CONMED Corporation
CNMD
|
2.33 B | $ 37.08 | 1.42 % | $ 1.15 B | ||
|
Smith & Nephew plc
SNN
|
10.4 B | - | - | $ 23.8 B | ||
|
Soliton, Inc.
SOLY
|
33.8 M | - | -1.42 % | $ 435 M | ||
|
Sensus Healthcare
SRTS
|
53 M | $ 4.22 | 6.57 % | $ 68.9 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
10.5 K | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
64.1 M | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
3.63 M | - | - | $ 1.08 M | ||
|
Electromed
ELMD
|
53.8 M | $ 24.66 | -0.16 % | $ 208 M | ||
|
Misonix, Inc.
MSON
|
204 M | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
66.2 M | - | - | $ 111 M | ||
|
Tactile Systems Technology
TCMD
|
274 M | $ 26.96 | 0.37 % | $ 617 M | ||
|
TELA Bio
TELA
|
78 M | $ 0.69 | -9.35 % | $ 15.8 M | ||
|
Intersect ENT, Inc.
XENT
|
227 M | - | - | $ 955 M | ||
|
Tandem Diabetes Care
TNDM
|
881 M | $ 24.26 | -1.02 % | $ 1.65 B | ||
|
Cytosorbents Corporation
CTSO
|
47.4 M | $ 0.67 | -3.52 % | $ 36.5 M | ||
|
Aethlon Medical
AEMD
|
7.36 M | $ 2.32 | 7.41 % | $ 3.62 M | ||
|
BIOLASE
BIOL
|
35.1 M | - | -13.19 % | $ 166 K | ||
|
InspireMD
NSPR
|
69.4 M | $ 1.77 | -1.12 % | $ 114 M | ||
|
AdaptHealth Corp.
AHCO
|
4.32 B | $ 11.39 | -0.78 % | $ 1.54 B | ||
|
Penumbra
PEN
|
1.83 B | $ 336.27 | 0.63 % | $ 13.1 B | ||
|
Myomo
MYO
|
38.6 M | $ 0.7 | -0.1 % | $ 29.3 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
210 M | $ 2.29 | -4.58 % | $ 134 M | ||
|
Invacare Corporation
IVC
|
771 M | - | - | $ 24.7 M | ||
|
EDAP TMS S.A.
EDAP
|
86.1 M | $ 3.71 | -5.12 % | $ 138 M | ||
|
OrthoPediatrics Corp.
KIDS
|
509 M | $ 16.23 | 2.01 % | $ 381 M | ||
|
Outset Medical
OM
|
264 M | $ 3.53 | - | $ 53.7 K | ||
|
Inspire Medical Systems
INSP
|
907 M | $ 51.41 | -1.27 % | $ 1.51 B | ||
|
Varex Imaging Corporation
VREX
|
1.11 B | $ 10.69 | 0.66 % | $ 443 M |